Jeffrey S Isenberg

8PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursUrban planning and healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 09, 2026
If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune Tolerance.

Enrique Montero, Jeffrey S Isenberg

|Jan 20, 2025
Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes.

Jeffrey S Isenberg, Fouad Kandeel

|Mar 18, 2024
CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair.

Robert L Zondervan, Christina A Capobianco, Daniel C Jenkins

|Feb 16, 2024
Tolerating CD47.

Jeffrey S Isenberg, Enrique Montero

|May 22, 2023
The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint era.

Enrique Montero, Jeffrey S Isenberg

|Feb 15, 2023
Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata.

Neslihan Erdem, Kuan-Tsen Chen, Meirigeng Qi

Pageof 2